Diversifying Therapeutic Strategies for Glioblastoma & Alzheimer’s Disease

Time: 3:00 pm
day: Day One


  • Diverse non-coding RNAs regulate all biological functions in a cell and expand the landscape of therapeutic targets in the CNS pathologies
  • Malignant brain tumors are a major unmet need in neuro-oncology, and oligonucleotides as future therapeutics for glioblastoma
  • Oligonucleotides could provide neuroprotection for neurodegenerative diseases such as Alzheimer’s